SAN DIEGO, May 07, 2018 -- ADHD in children is one of the most commonly diagnosed disorders in the 21st century. Attention Deficit Hyperactive Disorder, also known as ADHD, is diagnosed when a child under the age of seven meets six or more specific criteria determined by the American Academy of Pediatrics, including squirming and fidgeting, being in constant motion, having difficulty listening, being easily distracted, talking excessively, frequently interrupting conversations, having trouble finishing tasks, and displaying problem playing quietly. Children over the age of seven can be diagnosed; however, they are classified differently than younger children.
|
|||||
ADHD In Children
There are four distinct types of ADHD in children. The first is Combined Type ADHD (Inattentive/Hyperactive/Impulsive), which is the most common type. Children with Combined Type ADHD exhibit inattentiveness, hyperactivity, and impulsivity, as suggested by its classification name. These children are what most people think of when the ADHD is discussed. The second classification of ADHD, Hyperactive/Impulsive Type, categorizes children who display mostly impulsive and hyperactive behaviors but are not inattentive and generally do not have trouble following directions in a school setting. Most often these children are males, but it is not unheard of for females children to meet these criteria.
Contrary to popular belief, not all children with ADHD are hyperactive. The third type of ADHD is the Inattentive Type. While these children aren’t hyper or impulsive, they are inattentive and have problems following directions or staying on task. Children who meet the criteria for this type of ADHD are typically females, but again, in some instances, males receive this diagnosis if they reach six or more of the criteria. Lastly, diagnosing ADHD in children is not always cut-and-dry. Attention Hyperactive Disorder Not Otherwise Specified, also referred to as ADHD NOS, is a catchall for patients who seem to exhibit most behaviors associated with ADHD, but cannot be diagnosed due to the symptoms not meeting specific criteria. The diagnosis of ADHD NOS is frequently assigned to children over the age of seven, who meet all of the guidelines for diagnosis, but because of the age stipulation for diagnosis, cannot be diagnosed in the other three categories.
While treatment for each child varies, the most commonly prescribed medications for ADHD in children are stimulants under the trade names Ritalin and Adderall. Although stimulants typically increase activity for the general population, in children with ADHD the effects are much different, aiding in focusing and helping the child ignore distracting stimuli. Another common treatment is behavioral therapy, which centers on providing routines, structure, and a comfortably appropriate environment for the individual child. It may include parenting skills training to educate parents on how to properly handle or discipline their child with ADHD and social support groups.
ADHD In Children – Conclusion
Pediatricians and Psychologists both agree that the most effective form of treatment for ADHD patients is a combination of both therapy and the right medication. Each child may react differently to medications and types of treatment, but the research shows that the majority of children respond positively to a combination of both forms of treatment. ADHD in children has been researched more than any other childhood disorder, making diagnosis and treatment a useful process for frustrated and overwhelmed parents. When signs of medication abuse is present among patients, please call TheRecover.com and ask for the closest drug rehabilitation treatment centers.
Contact Info:
Author: Kevin Leonard
Organization: TheRecover.com
Address: 27420 Jefferson Ave, Temecula, CA 92590
Phone: (888) 510-3898
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/08ed1f01-f963-460a-b5d7-2d03dbe8d783


Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
TetherMax Rebranding Highlights Official Exchange Partnerships and Transparent Operations
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
China 618 Smartphone Sales Drop 13% as Higher Prices Hurt Demand, Huawei Gains Market Share
Meta Says States Seek $1.4 Trillion in Penalties Over Teen Social Media Addiction Lawsuit
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Shell Raises Q2 Upstream Outlook, Flags Qatar Gas Hit as Shares Rise
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
SpaceX Stock Draws Bullish Wall Street Coverage Ahead of Nasdaq-100 Inclusion
Barclays Downgrades Siemens Energy as Valuation Seen Near Peak
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom 



